Zimmer Biomet Holdings (ZBH) Liabilities from Discontinued Operations (2021)

Zimmer Biomet Holdings (ZBH) recorded quarterly Liabilities from Discontinued Operations of 61300000.0 in Q4 2021.

Zimmer Biomet Holdings (ZBH) Liabilities from Discontinued Operations (2021) Analysis & Trends

Zimmer Biomet Holdings' Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 61300000.0 for Q4 2021.

  • In Q4 2021, Liabilities from Discontinued Operations changed N/A year-over-year to 61300000.0; the TTM figure through Dec 2021 stood at 61300000.0 (changed N/A YoY), while the FY2021 annual figure was 61300000.0, changed N/A from the prior year.
  • Liabilities from Discontinued Operations was 61300000.0 for Q4 2021 at Zimmer Biomet Holdings.
  • In the past five years, Liabilities from Discontinued Operations ranged from a high of 61300000.0 in Q4 2021 to a low of 61300000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn

Historic Data

Download Data
DateValue
Dec 31, 2021 61.30 Mn
Dec 31, 2021 61.30 Mn